510 related articles for article (PubMed ID: 25436214)
21. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Tsurumoto T; Kono M; Shindo H; Ida H; Origuchi T; Eguchi K
J Rheumatol; 2009 Nov; 36(11):2397-402. PubMed ID: 19797510
[TBL] [Abstract][Full Text] [Related]
22. Regulatory effect of nicotine on the differentiation of Th1, Th2 and Th17 lymphocyte subsets in patients with rheumatoid arthritis.
Wu S; Zhou Y; Liu S; Zhang H; Luo H; Zuo X; Li T
Eur J Pharmacol; 2018 Jul; 831():38-45. PubMed ID: 29715455
[TBL] [Abstract][Full Text] [Related]
23. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
Su CC; Lin HC; Lin YP; Shan YS; Yang BC
Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
[TBL] [Abstract][Full Text] [Related]
24. Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
Yoshida Y; Ogata A; Kang S; Ebina K; Shi K; Nojima S; Kimura T; Ito D; Morimoto K; Nishide M; Hosokawa T; Hirano T; Shima Y; Narazaki M; Tsuboi H; Saeki Y; Tomita T; Tanaka T; Kumanogoh A
Arthritis Rheumatol; 2015 Jun; 67(6):1481-90. PubMed ID: 25707877
[TBL] [Abstract][Full Text] [Related]
25. Blocking of LFA-1 enhances expansion of Th17 cells induced by human CD14(+) CD16(++) nonclassical monocytes.
Traunecker E; Gardner R; Fonseca JE; Polido-Pereira J; Seitz M; Villiger PM; Iezzi G; Padovan E
Eur J Immunol; 2015 May; 45(5):1414-25. PubMed ID: 25678252
[TBL] [Abstract][Full Text] [Related]
26. CD147 modulates the differentiation of T-helper 17 cells in patients with rheumatoid arthritis.
Yang H; Wang J; Li Y; Yin ZJ; Lv TT; Zhu P; Zhang Y
APMIS; 2017 Jan; 125(1):24-31. PubMed ID: 27859685
[TBL] [Abstract][Full Text] [Related]
27. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
28. Resistin Gene Expression is Downregulated in CD4(+) T Helper Lymphocytes and CD14(+) Monocytes in Rheumatoid Arthritis Responding to TNF-α Inhibition.
Nagaev I; Andersen M; Olesen MK; Nagaeva O; Wikberg J; Mincheva-Nilsson L; Andersen GN
Scand J Immunol; 2016 Oct; 84(4):229-36. PubMed ID: 27434862
[TBL] [Abstract][Full Text] [Related]
29. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23.
Paulissen SM; van Hamburg JP; Davelaar N; Asmawidjaja PS; Hazes JM; Lubberts E
J Immunol; 2013 Aug; 191(3):1364-72. PubMed ID: 23817417
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
[TBL] [Abstract][Full Text] [Related]
31. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
Garfield BE; Krahl T; Appel S; Cooper SM; Rincón M
Clin Immunol; 2005 Aug; 116(2):101-7. PubMed ID: 15914087
[TBL] [Abstract][Full Text] [Related]
32. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.
Tanida S; Yoshitomi H; Ishikawa M; Kasahara T; Murata K; Shibuya H; Ito H; Nakamura T
Cytokine; 2011 Aug; 55(2):237-44. PubMed ID: 21592822
[TBL] [Abstract][Full Text] [Related]
33. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
[TBL] [Abstract][Full Text] [Related]
34. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
35. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Lee KA; Lee SH
Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
[TBL] [Abstract][Full Text] [Related]
38. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
Bryl E; Vallejo AN; Matteson EL; Witkowski JM; Weyand CM; Goronzy JJ
Arthritis Rheum; 2005 Oct; 52(10):2996-3003. PubMed ID: 16200579
[TBL] [Abstract][Full Text] [Related]
39. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
[TBL] [Abstract][Full Text] [Related]
40. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]